Aug 2026· Organoids· Vol 5, pp. 26· 0 citations· 60 references
TL;DR
This review systematically examines how the defining properties of bioactive ceramics intersect with the requirements of organoid formation, maturation, and transplantation and proposes that the deliberate co-design of bioactive ceramics and organoid biology represents a paradigm shift in regenerative medicine.
Abstract
Organoids are three-dimensional, stem-cell-derived tissue constructs that recapitulate the architecture and function of native organs, and they have rapidly emerged as transformative tools in regenerative medicine. Their translation from laboratory models to clinical therapies remains constrained, however, by the limitations of conventional culture matrices. Matrigel is the most widely used matrix. It suffers from batch-to-batch variability, an undefined composition, poor mechanical tunability, and a lack of instructive bioactivity. Bioactive ceramics offer a compelling alternative. Encompassing silicate-, phosphate-, and oxide-based formulations, these materials provide controllable ion-release profiles and structural versatility. They also possess a proven capacity to modulate cell behavior through biochemical and biophysical cues. This review systematically examines how the defining properties of bioactive ceramics intersect with the requirements of organoid formation, maturation, and transplantation. We focus on four key properties: ion release, surface bioactivity, mechanical support, and immunomodulation. We survey established and emerging combinations across bone, liver, intestine, biliary, and thyroid organoid systems. Fabrication strategies, including 3D-printed and sol–gel-derived ceramic scaffolds, are also discussed. Finally, we critically assess remaining challenges in vascularization, immune compatibility, and clinical scale-up, and we propose that the deliberate co-design of bioactive ceramics and organoid biology represents a paradigm shift in regenerative medicine. This approach offers a path toward functional, transplantable tissue constructs with genuine therapeutic potential.
The locomotor system organoids, which recapitulate bones, cartilage, tendons, muscles, and associated neurovascular-like structures, possess complex architecture and biomechanical properties. Traditional two-dimensional (2D) cell models struggle to effectively mimic their physiological functions. Organoid technology,...
Rui Wang, Ye Tian, Geng-Hao Wang et al.· Regenerative Biomaterials· 0 citations
This Mini-Review summarizes recent advances in natural, synthetic, and hybrid biomaterials, highlighting engineered ECM–derived hydrogels, modified natural polymers, and synthetic systems with tunable viscoelasticity, degradability, and bioactive components.
Laura Klasen, Ramin Nasehi, Lennart Selzener et al.· Frontiers in Bioengineering...· 0 citations
Osteochondral defects, frequently resulting from trauma, infection, or degenerative joint disease, present a significant clinical challenge due to their limited intrinsic healing capacity. Conventional cell-based therapies face limitations including immune rejection, high costs, and regulatory hurdles. Endogenous tissu...
Ling Zhang, Xuan Liu, Jin-Ping Liang et al.· Regenerative Therapy· 0 citations
The current review offers a complete review of the key aspects associated with the development of 3D bioprinting bioinks, including design concepts, classification, properties, and latest trends.
Shruti R. Balkawade, Devika Sajeev, U. Nayak· ACS Omega· 0 citations
Articular cartilage has limited intrinsic repair capacity, and current clinical approaches often fail to restore durable hyaline cartilage. Three-dimensional bioprinting offers spatial control over cells, biomaterials, and bioactive cues, creating opportunities to fabricate patient-specific constructs that recapitulate...
He-Bin Ma, Zhen Yang, Ya-Jing Li et al.· International Journal of Bio...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.